Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works

Trimmomatic: a flexible trimmer for Illumina sequence data

Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829 · see citing works

Analysis of protein-coding genetic variation in 60,706 humans

Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587 · see citing works

Bootstrap Methods and their Application

Davison, A. C., & Hinkley, D. V. (1997) · doi:10.1017/cbo9780511802843 · Cited by 7,350 · see citing works

The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments

Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231 · see citing works

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654 · cited 2× · see citing works

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,081 · see citing works

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975 · cited 1× · see citing works

Fast gene set enrichment analysisPreprint

Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,742 · see citing works

GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor

Davis, S. R., & Meltzer, P. S. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm254 · Cited by 3,289 · see citing works

The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote

Liao, Y., Smyth, G. K., & Shi, W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt214 · Cited by 3,064 · see citing works

BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis

Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S. R., Moor, B. D., Brāzma, A., & Huber, W. K. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti525 · Cited by 2,327 · see citing works

Idiopathic pulmonary fibrosis

King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194 · see citing works

A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1

Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · see citing works

Idiopathic Pulmonary Fibrosis

Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056 · see citing works

Idiopathic pulmonary fibrosis

Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020 · see citing works

Clinical course and prediction of survival in idiopathic pulmonary fibrosis

Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · see citing works

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

Ashcroft, T., Simpson, J. M., & Timbrell, V. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,692 · see citing works

Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis

The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,631 · see citing works

Cellular senescence mediates fibrotic pulmonary disease

Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · see citing works

Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors

Johnsson, B., Löfås, S., & Lindquist, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90424-r · Cited by 1,272 · see citing works

Genetic compensation induced by deleterious mutations but not gene knockdowns

Rossi, A., Kontarakis, Z., Gerri, C., Nolte, H., Hölper, S., Krüger, M., & Stainier, D. Y. R. (2015) · Nature · doi:10.1038/nature14580 · Cited by 1,249 · see citing works

Mechanisms of Pulmonary Fibrosis

Thannickal, V. J., Toews, G. B., White, E. S., Lynch, J. P., & Martínez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 806 · see citing works

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718 · see citing works

The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers

Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 682 · see citing works

IL-11 is a crucial determinant of cardiovascular fibrosis

Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., et al. (2017) · Nature · doi:10.1038/nature24676 · Cited by 639 · see citing works

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis

Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633 · see citing works

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

King, T. E., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60551-1 · Cited by 531 · see citing works

Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema

Morris, D. G., Huang, X., Kaminski, N., Wang, Y., Shapiro, S. D., Dolganov, G., Glick, A. B., & Sheppard, D. (2003) · Nature · doi:10.1038/nature01413 · Cited by 500 · see citing works

The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed · Cited by 482 · see citing works

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

Jenkins, G. R., Moore, B. B., Chambers, R. C., Eickelberg, O., Königshoff, M., Kolb, M. R. J., Laurent, G. J., Nanthakumar, C. B., Olman, M. A., Pardo, A., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0096st · Cited by 446 · see citing works

Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 434 · see citing works

TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?

Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramı́rez, R., Barrios, R. J., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 426 · see citing works

Animal Models of Fibrotic Lung Disease

Moore, B. B., Lawson, W. E., Oury, T. D., Sisson, T. H., Raghavendran, K., & Hogaboam, C. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0094tr · Cited by 417 · see citing works

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease

Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 403 · see citing works

Platelet-derived growth factor in idiopathic pulmonary fibrosis.

Antoniades, H. N., Bravo, M. A., Avila, R. E., Galanopoulos, T., Neville-Golden, J., Maxwell, M., & Selman, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114808 · Cited by 386 · see citing works

Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44

Li, Y., Jiang, D., Liang, J., Meltzer, E. B., Gray, A., Miura, R., Wogensen, L., Yamaguchi, Y., & Noble, P. W. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102510 · Cited by 382 · see citing works

Imatinib Treatment for Idiopathic Pulmonary Fibrosis: Randomized Placebo-controlled Trial Results

Daniels, C. E., Lasky, J. A., Limper, A. H., Mieras, K., Gabor, E., & Schroeder, D. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0964oc · Cited by 373 · see citing works

Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial

Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370 · see citing works

A general framework for multiple testing dependence

Leek, J. T., & Storey, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808709105 · Cited by 365 · see citing works

Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model

Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 359 · see citing works

Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function

Yu, G., Τzouvelekis, Α., Wang, R., Herazo‐Maya, J. D., Ibarra, G. H., Srivastava, A., Werneck‐de‐Castro, J. P., DeIuliis, G., Ahangari, F., Woolard, T., et al. (2017) · Nature Medicine · doi:10.1038/nm.4447 · Cited by 356 · see citing works

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., Glaspole, I., Glassberg, M. K., Kardatzke, D. R., Daigl, M., Kirchgaessler, K.-U., Lancaster, L. H., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30326-5 · Cited by 335 · see citing works

Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice

Yang, Z., Mu, Z., Dabovic, B., Jurukovski, V., Yu, D., Sung, J. J., Xiong, X., & Munger, J. S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611044 · Cited by 321 · see citing works

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial

Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277 · see citing works

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 276 · see citing works

Increased Endothelin-1 in Bleomycin-induced Pulmonary Fibrosis and the Effect of an Endothelin Receptor Antagonist

PARK, S.-H., Saleh, D. M., Giaid, A., & Michel, R. P. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9607123 · Cited by 244 · see citing works

Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells

Strikoudis, A., Cieślak, A., Loffredo, L., Chen, Y.-W., Patel, N., Saqi, A., Lederer, D. J., & Snoeck, H.-W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.077 · Cited by 242 · see citing works

Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice

Aono, Y., Nishioka, Y., Inayama, M., Ugai, M., Kishi, J., Uehara, H., Izumi, K., & Sone, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-531oc · Cited by 231 · see citing works

Ligand-Dependent Genetic Recombination in Fibroblasts

Zheng, B., Zhang, Z., Black, C. M., Crombrugghe, B. D., & Denton, C. P. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61108-x · Cited by 227 · see citing works

Mice that lack activity of αvβ6- and αvβ8-integrins reproduce the abnormalities of Tgfb1 - and Tgfb3 -null mice

Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P. H., Horan, G. S. B., Violette, S. M., & Munger, J. S. (2008) · Journal of Cell Science · doi:10.1242/jcs.035246 · Cited by 224 · see citing works

Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction.

Tang, W., Geba, G. P., Zheng, T., Ray, P., Homer, R. J., Kuhn, C., Flavell, R. A., & Elias, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119113 · Cited by 210 · see citing works

Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth

Nieminen, P., Morgan, N. V., Fenwick, A. L., Parmanen, S., Veistinen, L., Mikkola, M. L., van der Spek, P. J., Giraud, A. S., Judd, L. M., Arte, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.024 · Cited by 200 · see citing works

DNase I-hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells

Yata, Y., Scanga, A. E., Gillan, A., Yang, L., Reif, S. S., Breindl, M., Brenner, D. A., & Rippe, R. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50067 · Cited by 192 · see citing works

A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis

Bauer, Y., Tedrow, J., de Bernard, S., Birker-Robaczewska, M., Gibson, K. F., Guardela, B. J., Hess, P., Klenk, A., Lindell, K. O., Poirey, S., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0310oc · Cited by 182 · see citing works

Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.

Waxman, A. B., Einarsson, Ó., Seres, T., Knickelbein, R. G., Warshaw, J. B., Johnston, R. B., Homer, R., & Elias, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1337 · Cited by 177 · see citing works

Therapeutic Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-11 Ameliorates Cardiac Fibrosis After Myocardial Infarction

Obana, M., Maeda, M., Takeda, K., Hayama, A., Mohri, T., Yamashita, T., Nakaoka, Y., Komuro, I., Takeda, K., Matsumiya, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.893677 · Cited by 172 · see citing works

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

Kakugawa, T., Mukae, H., Hayashi, T., Ishii, H., Abe, K., Fujii, T., Oku, H., Miyazaki, M., Kadota, J., & KOHNO, S. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120803 · Cited by 167 · see citing works

Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis

Nandurkar, H. H., Robb, L., Tarlinton, D. M., Barnett, L. D., Köntgen, F., & Begley, C. G. (1997) · Blood · doi:10.1182/blood.v90.6.2148 · Cited by 166 · see citing works

Fibroblasts Isolated from Normal Lungs and Those with Idiopathic Pulmonary Fibrosis Differ in Interleukin-6/gp130-Mediated Cell Signaling and Proliferation

Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., McAnulty, R. J., Laurent, G. J., Mutsaers, S. E., Thompson, P. J., & Knight, D. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63658-9 · Cited by 165 · see citing works

Elevated Expression of Endothelin-1 and Endothelin-Converting Enzyme-1 in Idiopathic Pulmonary Fibrosis: Possible Involvement of Proinflammatory Cytokines

Saleh, D. M., Furukawa, K., Tsao, M., Maghazachi, A. A., CORRIN, B., Yanagisawa, M., Barnes, P. J., & Giaid, A. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.2.9032126 · Cited by 165 · see citing works

Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.

Ray, P., Tang, W., Wang, P., Homer, R. J., Kuhn, C., Flavell, R. A., & Elias, J. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119792 · Cited by 156 · see citing works

Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis

Mozaffarian, A., Brewer, A. W., Trueblood, E. S., Luzina, I. G., Todd, N. W., Atamas, S. P., & Arnett, H. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7243 · Cited by 153 · see citing works

Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis

Xie, T., Liang, J., Liu, N., Huan, C., Zhang, Y., Liu, W., Kumar, M. E., Xiao, R., D'Armiento, J. M., METZGER, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85328 · Cited by 137 · see citing works

Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.

Waxman, A., Einarsson, Ó., Seres, T., Knickelbein, R., Warshaw, J., Johnston, R., Homer, R. J., & Elias, J. A. (1999) · Chest · doi:10.1378/chest.116.suppl_1.8s · Cited by 136 · see citing works

Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer

Bierie, B., Chung, C. H., Parker, J. S., Stover, D. G., Cheng, N., Chytil, A. M., Aakre, M. E., Shyr, Y., & Moses, H. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37480 · Cited by 134 · see citing works

Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determinationPreprint

Teng, F., Xia, K., Li, Z., Zhou, B., Zhu, S., Chen, H., Zhang, J., Chen, Z., Xiao, H., Han, J.-D. J., et al. (2009) · Genome Research · doi:10.1101/gr.092114.109 · Cited by 129 · see citing works

A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis

Parker, J. M., Glaspole, I. N., Lancaster, L. H., Haddad, T. J., She, D., Roseti, S. L., Fiening, J. P., Grant, E. P., Kell, C. M., & Flaherty, K. R. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0784oc · Cited by 129 · see citing works

PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis

Geng, Y., Liu, X., Liang, J., Habiel, D. M., Kulur, V., Coelho, A. L., Deng, N., Xie, T., Wang, Y., Liu, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125326 · Cited by 124 · see citing works

Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model

Murray, L. A., Zhang, H., Oak, S. R., Coelho, A. L., Herath, A., Flaherty, K. R., Lee, J. S., Bell, M., Knight, D. A., Martínez, F. J., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0342oc · Cited by 117 · see citing works

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease

Lindahl, G. E., Stock, C. J. W., Shiwen, X., Leoni, P., Sestini, P., Howat, S., Bou–Gharios, G., Nicholson, A. G., Denton, C. P., Grutters, J. C., et al. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-80 · Cited by 103 · see citing works

Transcriptome Analysis Reveals Differential Splicing Events in IPF Lung Tissue

Nance, T., Smith, K. S., Anaya, V., Richardson, R., Ho, L. A., Pala, M., Mostafavi, S., Battle, A. J., Feghali‐Bostwick, C. A., Rosen, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092111 · Cited by 95 · see citing works

β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix

Lovgren, A. K., Kovacs, J. J., Xie, T., Potts, E. N., Li, Y., Foster, W. M., Liang, J., Meltzer, E. B., Jiang, D., Lefkowitz, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001564 · Cited by 89 · see citing works

IL-11 Receptor α in the Pathogenesis of IL-13-Induced Inflammation and Remodeling

Chen, Q., Rabach, L. A., Noble, P. W., Zheng, T., Lee, C. G., Homer, R., & Elias, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2305 · Cited by 73 · see citing works

A Novel IκB Kinase-β Inhibitor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Mice

Inayama, M., Nishioka, Y., Azuma, M., Muto, S., Aono, Y., Makino, H., Tani, K., Uehara, H., Izumi, K., Itai, A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-947oc · Cited by 69 · see citing works

Interleukin-11 protects against renal ischemia and reperfusion injury

Lee, H. T., Park, S. W., Kim, M., Ham, A., Anderson, L. J., Brown, K. M., D’Agati, V. D., & Cox, G. N. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00220.2012 · Cited by 67 · see citing works

Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice

Murakami, S., Nagaya, N., Itoh, T., Kataoka, M., Iwase, T., Horio, T., Miyahara, Y., Sakai, Y., Kangawa, K., & Kimura, H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00042.2005 · Cited by 67 · see citing works

Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine

Kimura, R., Maeda, M., Arita, A., Oshima, Y., Obana, M., Ito, T., Yamamoto, Y., Mohri, T., Kishimoto, T., Kawase, I., et al. (2007) · Cytokine · doi:10.1016/j.cyto.2007.05.011 · Cited by 64 · see citing works

IL-11: insights in asthma from overexpression transgenic modeling.

Zheng, T., Zhu, Z., Wang, J.-M., Homer, R. J., & Elias, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118510 · Cited by 60 · see citing works

Local Administration of Interleukin-11 Ameliorates Intestinal Radiation Injury in Rats

Boerma, M., Wang, J., Burnett, A., Santin, A. D., Roman, J. J., & Hauer‐Jensen, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0810 · Cited by 56 · see citing works

Protective Effect of rhIL-11 in a Murine Model of Acetaminophen-Induced Hepatotoxicity

Trepicchio, W. L., Bozza, M., Bouchard, P. R., & Dorner, A. J. (2001) · Toxicologic Pathology · doi:10.1080/019262301317052521 · Cited by 45 · see citing works

Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis

Luzina, I. G., Lockatell, V., Hyun, S. W., Kopach, P., Kang, P. H., Noor, Z., Liu, A., Lillehoj, E. P., Lee, C., Miranda-Ribera, A., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00346.2015 · Cited by 42 · see citing works

Recombinant Human Interleukin-11 Modulates Ion Transport and Mucosal Inflammation in the Small Intestine and Colon

Meerveld, B. G., Tyler, K. R., & Keith, J. C. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780135 · Cited by 39 · see citing works

Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis

Xie, T., Liang, J., Liu, N., Huan, C., Zhang, Y., Liu, W., Kumar, M. E., Xiao, R., D'Armiento, J. M., METZGER, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci89968 · Cited by 39 · see citing works

IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice

Zhu, M., Lu, B., Cao, Q., Wu, Z., Xu, Z., Li, W., Yao, X., & Liu, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126296 · Cited by 35 · see citing works

Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury

Sheridan, B. C., Dinarello, C. A., Meldrum, D. R., Fullerton, D. A., Selzman, C. H., & McIntyre, R. C. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.5.l861 · Cited by 35 · see citing works

IL11RA‐ related Crouzon‐like autosomal recessive craniosynostosis in 10 new patients: Resemblances and differences

Brischoux‐Boucher, E., Trimouille, A., Baujat, G., Goldenberg, A., Schaefer, É., Guichard, B., Hannequin, P., D, G. P. M., Baer, S., Cabrol, C., et al. (2018) · Clinical Genetics · doi:10.1111/cge.13409 · Cited by 32 · see citing works

Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats

Stangou, M. J., Bhangal, G., Lai, P., Smith, J., Keith, J. C., Boyle, J. J., Pusey, C. D., Cook, T. H., & Tam, F. W. K. (2010) · Journal of Nephrology · doi:10.5301/jn.2010.5094 · Cited by 12 · see citing works

Correction: Transcriptome Analysis Reveals Differential Splicing Events in IPF Lung Tissue

Staff, T. P. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097550 · Cited by 10 · see citing works

Fibrosis: from mechanisms to medicines

Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · see citing works

Cardiac fibrosis

Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229 · see citing works

Targeting IL-6 trans-signalling: past, present and future prospects

Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524 · see citing works

Current treatment paradigms and emerging therapies for NAFLD/NASH

Raza, S. (2020) · Frontiers in bioscience · doi:10.2741/4892 · Cited by 323 · see citing works

TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities

Budi, E. H., Schaub, J. R., Decaris, M. L., Turner, S., & Derynck, R. (2021) · The Journal of Pathology · doi:10.1002/path.5680 · Cited by 300 · see citing works

Contributions of alveolar epithelial cell quality control to pulmonary fibrosis

Katzen, J. B., & Beers, M. F. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139519 · Cited by 289 · see citing works

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 276 · see citing works

Immune Cells and Immunotherapy for Cardiac Injury and Repair

Rurik, J. G., Aghajanian, H. K., & Epstein, J. A. (2021) · Circulation Research · doi:10.1161/circresaha.121.318005 · Cited by 270 · see citing works

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 260 · see citing works

The mesenchymal context in inflammation, immunity and cancer

Koliaraki, V., Prados, A., Armaka, M., & Kollias, G. A. (2020) · Nature Immunology · doi:10.1038/s41590-020-0741-2 · Cited by 247 · see citing works

Fibroblast pathology in inflammatory diseases

Wei, K., Nguyen, H. N., & Brenner, M. B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149538 · Cited by 244 · see citing works

Role of interleukins in the pathogenesis of pulmonary fibrosis

She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 226 · see citing works

TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)

Ye, Z., & Hu, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4965 · Cited by 226 · see citing works

COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts

John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219 · see citing works

Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments

Tang, X., Li, P., & Chen, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00280 · Cited by 218 · see citing works

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 195 · see citing works

Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge

Bai, X., Zhao, G., Chen, Q., Li, Z., Gao, M., Ho, W., Xu, X., & Zhang, X. (2022) · Science Advances · doi:10.1126/sciadv.abn7162 · Cited by 191 · see citing works

Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation

Cook, S. A., & Schäfer, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-041818-011649 · Cited by 176 · see citing works

Immunology of human fibrosis

Bhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148 · see citing works

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

Dong, J., Viswanathan, S., Adami, E., Singh, B. K., Chothani, S. P., Ng, B., Lim, W., Zhou, J., Tripathi, M., Ko, N. S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20303-z · Cited by 125 · see citing works

Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches

Glass, D. S., Grossfeld, D. J., Renna, H. A., Agarwala, P., Spiegler, P. A., Kasselman, L. J., Glass, A. D., DeLeon, J. R., & Reiss, A. B. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.04.002 · Cited by 124 · see citing works

Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines

West, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01093 · Cited by 119 · see citing works

Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis

Han, D., Gong, H., Wei, Y., Xu, Y., Zhou, X., Wang, Z., & Feng, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154680 · Cited by 118 · see citing works

Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing

Jasso, G. J., Jaiswal, A., Varma, M., Laszewski, T., Grauel, A. L., Omar, A. S., Silva, N., Dranoff, G., Porter, J. A., Mansfield, K. G., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001532 · Cited by 113 · see citing works

Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11

Metcalfe, R. D., Putoczki, T. L., & Griffin, M. D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01424 · Cited by 112 · see citing works

Emerging roles for IL-11 in inflammatory diseases

Fung, K. Y., Louis, C., Metcalfe, R. D., Kosasih, C. C., Wicks, I. P., Griffin, M. D. W., & Putoczki, T. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155750 · Cited by 104 · see citing works

Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway

Ng, B., Cook, S. A., & Schäfer, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00531-5 · Cited by 98 · see citing works

IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system

Seyedsadr, M., Wang, Y., Elzoheiry, M., Gopal, S. S., Jang, S., Duran, G., Chervoneva, I., Kasimoglu, E., Wrobel, J. A., Hwang, D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221007120 · Cited by 91 · see citing works

Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside

Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170499 · Cited by 87 · see citing works

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

Zapater, E. O., Signes‐Costa, J., Montero, P., & Roger, I. (2022) · Biomedicines · doi:10.3390/biomedicines10061423 · Cited by 83 · see citing works

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies

Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 83 · see citing works

IL‐11 in cardiac and renal fibrosis: Late to the party but a central player

Corden, B., Adami, E., Sweeney, M. D., Schäfer, S., & Cook, S. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15013 · Cited by 82 · see citing works

Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury

Widjaja, A. A., Dong, J., Adami, E., Viswanathan, S., Ng, B., Pakkiri, L. S., Chothani, S. P., Singh, B. K., Lim, W., Zhou, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba8146 · Cited by 82 · see citing works

Towards precision medicine in heart failure

Weldy, C. S., & Ashley, E. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00566-9 · Cited by 81 · see citing works

Interleukin-11 signaling promotes cellular reprogramming and limits fibrotic scarring during tissue regeneration

Allanki, S., Strilić, B., Scheinberger, L., Onderwater, Y. L., Marks, A., Günther, S., Preussner, J., Kikhi, K., Looso, M., Stainier, D. Y. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6497 · Cited by 81 · see citing works

Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart

Umbarkar, P., Tousif, S., Singh, A. P., Anderson, J. C., Zhang, Q., Tallquist, M. D., Woodgett, J. R., & Lal, H. (2022) · Circulation Research · doi:10.1161/circresaha.122.321431 · Cited by 81 · see citing works

Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?

van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 80 · see citing works

TGF-β and RAS jointly unmask primed enhancers to drive metastasis

Lee, J. H., Rivera, F. J. S., He, L. Y., Basnet, H., Chen, F., Spina, E., Li, L., Torner, C., Chan, J. E., Yarlagadda, D. V. K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.014 · Cited by 80 · see citing works

Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells

Kaiser, K. A., Loffredo, L. F., Santos-Alexis, K. D. L., Ringham, O. R., & Arpaia, N. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20221462 · Cited by 79 · see citing works

Vascular dysfunction in aged mice contributes to persistent lung fibrosis

Caporarello, N., Meridew, J. A., Aravamudhan, A., Jones, D. L., Austin, S. A., Pham, T. X., Haak, A. J., Choi, K. M., Tan, Q., Haresi, A. J., et al. (2020) · Aging Cell · doi:10.1111/acel.13196 · Cited by 79 · see citing works

Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease

Widjaja, A. A., Viswanathan, S., Shekeran, S. G., Adami, E., Lim, W., Chothani, S. P., Tan, J., Goh, J. W. T., Chen, H., Lim, S. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35306-1 · Cited by 79 · see citing works

Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice

Lim, W., Ng, B., Widjaja, A. A., Xie, C., Su, L., Ko, N. S. J., Lim, S.-Y., Kwek, X.-Y., Lim, S., Cook, S. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227505 · Cited by 77 · see citing works

Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis

Serezani, A. P. M., Pascoalino, B. D., Bazzano, J. M. R., Vowell, K. N., Tanjore, H., Taylor, C. J., Calvi, C. L., McCall, A. S., Bacchetta, M. D., Shaver, C. M., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0418oc · Cited by 77 · see citing works

Distinctive role of inflammation in tissue repair and regeneration

Choi, B., Lee, C., & Yu, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01428-3 · Cited by 75 · see citing works

Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling

Chen, Y., Wang, L., Huang, S., Ke, J.-F., Wang, Q., Zhou, Z., & Chang, W. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102020 · Cited by 73 · see citing works

Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis

Nanri, Y., Nunomura, S., Terasaki, Y., Yoshihara, T., Hirano, Y., Yokosaki, Y., Yamaguchi, Y., Feghali‐Bostwick, C. A., Ajito, K., Murakami, S., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0245oc · Cited by 72 · see citing works

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension

Roger, I., Milara, J., Montero, P., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094980 · Cited by 70 · see citing works

WNT/β-Catenin Signaling Promotes TGF-β-Mediated Activation of Human Cardiac Fibroblasts by Enhancing IL-11 Production

Działo, E., Czepiel, M., Tkacz, K., Siedlar, M., Kania, G., & Błyszczuk, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810072 · Cited by 70 · see citing works

Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease

Ng, B., Dong, J., Viswanathan, S., Widjaja, A. A., Paleja, B. S., Adami, E., Ko, N. S. J., Wang, M., Lim, S., Tan, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001045rr · Cited by 69 · see citing works

Understanding interleukin 11 as a disease gene and therapeutic target

Cook, S. A. (2023) · Biochemical Journal · doi:10.1042/bcj20220160 · Cited by 68 · see citing works

IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts

Adami, E., Viswanathan, S., Widjaja, A. A., Ng, B., Chothani, S. P., Tham, N., Tan, J., Lio, P. M., George, B. L., Altunoğlu, U., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab168 · Cited by 67 · see citing works

IL-6 family cytokines in respiratory health and disease

Dawson, R., Jenkins, B. J., & Saad, M. I. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155520 · Cited by 64 · see citing works

Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease

Kim, Y., Yang, H.-I., & Kim, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914509 · Cited by 63 · see citing works

Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization

Rui, Y., Han, X., Jiang, A., Hu, J., Li, M., Liu, B., Qian, F., & Huang, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175184 · Cited by 61 · see citing works

Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models

Lim, W., Corden, B., Ng, B., Vanezis, K., D’Agostino, G. A., Widjaja, A. A., Song, W., Xie, C., Su, L., Kwek, X.-Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74944-7 · Cited by 60 · see citing works

Sirt1 overexpression improves senescence‐associated pulmonary fibrosis induced by vitamin D deficiency through downregulating IL‐11 transcription

Zhou, J., Chen, H., Wang, Q., Chen, S., Wang, R., Wang, Z., Yang, C., Chen, A., Zhao, J., Zhou, Z., et al. (2022) · Aging Cell · doi:10.1111/acel.13680 · Cited by 59 · see citing works

Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma

Branco, F., Cunha, J., Mendes, M., Vitorino, C., & Sousa, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c01790 · Cited by 58 · see citing works

Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis

Tikhomirov, R., Reilly-O’Donnell, B., Catapano, F., Faggian, G. G., Gorelik, J., Martelli, F., & Emanueli, C. (2020) · Cells · doi:10.3390/cells9030592 · Cited by 56 · see citing works

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy

Widjaja, A. A., Chothani, S. P., & Cook, S. A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1761203 · Cited by 54 · see citing works

Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation

Györfi, A., Matei, A., Fuchs, M., Liang, C., Rigau, A. R., Hong, X., Zhu, H., Luber, M., Bergmann, C., Dees, C., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201916 · Cited by 52 · see citing works

Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

Xu, S., Yang, X., Chen, Q., Liu, Z., Chen, Y., Yao, X., Xiao, A., Tian, J., Xie, L., Zhou, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104312 · Cited by 52 · see citing works

Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis

Dong, S., Fang, H., Zhu, J., Wu, Z., Liu, Y., Zhu, J., Ma, B., Chen, Q., & Yang, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c15130 · Cited by 51 · see citing works

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis

Ma, H., Liu, S., Li, S., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918771 · Cited by 51 · see citing works

A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome

Widjaja, A. A., Shekeran, S. G., Adami, E., Ting, J. G. W., Tan, J., Viswanathan, S., Lim, S. Y., Tan, P. H., Hübner, N., Coffman, T. M., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021040577 · Cited by 50 · see citing works

Cellular and Molecular Mechanisms of Intestinal Fibrosis

Wu, X., Lin, X., Tan, J., Liu, Z., He, J., Hu, F., Wang, Y., Chen, M., Liu, F., & Mao, R. (2023) · Gut and Liver · doi:10.5009/gnl220045 · Cited by 50 · see citing works

Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects

Zheng, M., Zhu, W., Gao, F., Zhuo, Y., Mo, Z., Wu, G., & Feng, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02407-6 · Cited by 50 · see citing works

CD39+ Fibroblasts Enhance Myofibroblast Activation by Promoting IL-11 Secretion in Hypertrophic Scars

Huang, X., Gu, S., Liu, C., Zhang, L., Zhang, Z., Zhao, Y., Khoong, Y., Li, H., Gao, Y., Liu, Y., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.07.181 · Cited by 48 · see citing works

IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes

Skuratovskaia, D., Komar, A., Vulf, M. A., Quang, H. V., Shunkin, E. O., Volkova, L. V., Газатова, Н. Д., Затолокин, П. А., & Litvinova, L. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041774 · Cited by 48 · see citing works

Host IL11 Signaling Suppresses CD4+ T cell–Mediated Antitumor Responses to Colon Cancer in Mice

Huynh, J., Baloyan, D., Chisanga, D., Shi, W., O'Brien, M., Afshar‐Sterle, S., Alorro, M., Pang, L., Williams, D. S., Parslow, A. C., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-1023 · Cited by 48 · see citing works

Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis

Velagacherla, V., Mehta, C. H., Nayak, Y., & Nayak, U. Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120283 · Cited by 47 · see citing works

Interleukin-6–dependent epithelial fluidization initiates fibrotic lung remodeling

Stancil, I. T., Michalski, J. E., Hennessy, C. E., Hatakka, K. L., Yang, I. V., Kurche, J. S., Rincón, M., & Schwartz, D. A. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo5254 · Cited by 46 · see citing works

Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications

Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 46 · see citing works

Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis

Ng, B., Widjaja, A. A., Viswanathan, S., Dong, J., Chothani, S. P., Lim, S., Shekeran, S. G., Tan, J., McGregor, N. E., Walker, E. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93623-9 · Cited by 46 · see citing works

Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution

Martínez‐Hernández, R., de la Blanca, N. S., Sacristan-Gomez, P., Serrano-Somavilla, A., de Nova, J. L. M., Sánchez‐Cabo, F., Heyn, H., Sampedro-Nuñez, M. A., & Marazuela, M. (2024) · Nature Communications · doi:10.1038/s41467-024-50192-5 · Cited by 45 · see citing works

Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome

Lim, W., Dong, J., Ng, B., Widjaja, A. A., Xie, C., Su, L., Kwek, X.-Y., Tee, N., Pua, C. J., Schäfer, S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320381 · Cited by 45 · see citing works

Interleukin-11 drives human and mouse alcohol-related liver disease

Effenberger, M., Widjaja, A. A., Grabherr, F., Schaefer, B., Grander, C., Mayr, L., Schwärzler, J., Enrich, B., Moser, P. L., Fink, J., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326076 · Cited by 44 · see citing works

The cytokine interleukin-11 crucially links bone formation, remodeling and resorption

Kespohl, B., Schumertl, T., Bertrand, J., Lokau, J., & Garbers, C. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.04.002 · Cited by 42 · see citing works

Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases

Maroni, P., Bendinelli, P., Ferraretto, A., & Lombardi, G. (2021) · Biomedicines · doi:10.3390/biomedicines9060659 · Cited by 39 · see citing works

Polyphenols from Chinese Herbal Medicine: Molecular Mechanisms and Therapeutic Targets in Pulmonary Fibrosis

Wang, L., Zhu, T., Feng, D., Li, R., & Zhang, C. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500434 · Cited by 39 · see citing works

Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy

Allam, A. H., Yakou, M. H., Pang, L., Ernst, M., & Huynh, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767939 · Cited by 36 · see citing works

Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

Gerckens, M., Schorpp, K., Pelizza, F., Wögrath, M., Reichau, K., Ma, H., Dworsky, A.-M., Sengupta, A., Stoleriu, M. G., Heinzelmann, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb3673 · Cited by 36 · see citing works

Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant

Metcalfe, R. D., Hanssen, E. G., Fung, K. Y., Aizel, K., Kosasih, C. C., Zlatic, C. O., Doughty, L., Morton, C. J., Leis, A. P., Parker, M. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42754-w · Cited by 36 · see citing works

CB 1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

Çınar, R., Park, J. K., Zawatsky, C. N., Coffey, N. J., Bodine, S. P., Abdalla, J., Yokoyama, T., Jourdan, T., Jay, L., Zuo, M. X. G., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.471 · Cited by 35 · see citing works

The role of proteolysis in interleukin-11 signaling

Lokau, J., Kespohl, B., Kirschke, S., & Garbers, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119135 · Cited by 35 · see citing works

Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition

Li, Y., Luo, C., Zeng, Y., Zheng, Z., Tao, D., Liu, Q., Hong, Y., Wang, S., Long, H., & Xu, Z. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.07.005 · Cited by 34 · see citing works

Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics

Chen, T., Zhang, Z., Weng, D., Lu, L., Wang, X., Xing, M., Qiu, H., Zhao, M., Shen, L., Zhou, Y., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.013 · Cited by 34 · see citing works

IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy

Wu, P., Lin, B., Huang, S., Meng, J., Zhang, F., Zhou, M., Hei, X., Yu, K., Yang, H., & Huang, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.846106 · Cited by 34 · see citing works

HER2 drives lung fibrosis by activating a metastatic cancer signature in invasive lung fibroblasts

Liu, X., Geng, Y., Liang, J., Coelho, A. L., Yao, C., Deng, N., Wang, Y., Dai, K., Huang, G., Xie, T., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220126 · Cited by 34 · see citing works

The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view

Lazăr, M., Săndulescu, M., Barbu, E. C., Chițu, C. E., Andreescu, D. I., Anton, A. N., Erculescu, T. M., Petre, A. M., Duca, G. T., Simion, V., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030639 · Cited by 33 · see citing works

Inhalable myofibroblast targeting nanoparticles for synergistic treatment of pulmonary fibrosis

Chen, Z., Yang, J., Zhang, Q., Zeng, W., Liu, Y., Hu, W., Chen, L., Shen, J., Miao, Y., Xiao, Z., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv9571 · Cited by 32 · see citing works

Extracellular signal-regulated kinase signaling pathway and silicosis

Xie, Y. G., Ma, J., Yang, M., Fan, L., & Chen, W. (2021) · Toxicology Research · doi:10.1093/toxres/tfaa109 · Cited by 31 · see citing works

Deleterious Role of Th9 Cells in Pulmonary Fibrosis

Deng, K., Yang, X. S., Luo, Q., She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cells · doi:10.3390/cells10113209 · Cited by 31 · see citing works

Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment

Chen, X., Wang, Z., Han, S., Wang, Z., Zhang, Y., Li, X., Xia, N. L., Yu, W., Jia, C., Ni, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04403-2 · Cited by 31 · see citing works

Basal Cell–derived WNT7A Promotes Fibrogenesis at the Fibrotic Niche in Idiopathic Pulmonary Fibrosis

Huang, G., Liang, J., Huang, K. Y., Liu, X., Taghavifar, F., Yao, C., Parimon, T., Liu, N., Dai, K., Aziz, A. W., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0074oc · Cited by 31 · see citing works

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

Milara, J., Roger, I., Montero, P., Artigues, E., Escrivá, J., & Cortijo, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02241-0 · Cited by 31 · see citing works

Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis

Wang, Y., Wu, G., Yue, H., Zhou, Q. T., Zhang, L., He, L., Gu, W., Gao, R., Dong, L., Zhang, H., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.017 · Cited by 30 · see citing works

IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis

Ng, B., Viswanathan, S., Widjaja, A. A., Lim, W., Shekeran, S. G., Goh, J. W. T., Tan, J., Kuthubudeen, F. F., Lim, S. Y., Xie, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073549 · Cited by 30 · see citing works

Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD

Bachmann, J. C., Baumgart, S. J., Uryga, A., Bosteen, M. H., Borghetti, G., Nyberg, M., & Herum, K. M. (2022) · Cells · doi:10.3390/cells11101657 · Cited by 30 · see citing works

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

Leung, J. H., Ng, B., & Lim, W. (2022) · Cells · doi:10.3390/cells11142257 · Cited by 30 · see citing works

Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target

O’Reilly, S. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad108 · Cited by 29 · see citing works

IL-11 Is a Therapeutic Target in Idiopathic Pulmonary Fibrosis

Ng, B., Dong, J., Viswanathan, S., D’Agostino, G. A., Widjaja, A. A., Lim, W., Ko, N., Tan, J., Chothani, S. P., Chacko, A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1234 · Cited by 2 · see citing works

The strange case of IL-11

Maroso, M. (2019) · Science · doi:10.1126/science.365.6460.1414-s

Targeting IL-11 in idiopathic pulmonary fibrosis

(2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00183-9 · Cited by 5 · see citing works

Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway

Ng, B., Cook, S. A., & Schäfer, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00531-5 · Cited by 98 · see citing works

IL-11 neutralizing antibodies alleviate pulmonary fibrosis in aging mice by inhibiting TGF-β/NOX4/IL-11 signaling pathway

Miao, Y., Hu, Y. Q., Xu, L., Xu, L., Meng, L., Yang, Y., Liu, Z., Yang, Z., Liu, Y.-M., Liu, Y., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118204 · Cited by 1 · see citing works